Colorcon Announces New Starch Products Manufacturing Plant
A new starch manufacturing plant near Amsterdam, The Netherlands will give Colorcon customers a second source of supply.
Colorcon Inc. has announced plans to build a new starch manufacturing plant near Amsterdam, The Netherlands to double the existing manufacturing capacity for Starch 1500, pregelatinized maize starch, and support the continued growth of its excipient business.
The facility will produce GMP starch products for the pharmaceutical and nutritional markets served by the company in the EMEA region by 2022, according to a July 15, 2019 press statement.
“The plant will provide a secure second source of supply with the same quality, consistency and equivalency to the product manufactured in our existing facility in Indianapolis, IN,” said Nathan Evans, operations project manager, in the press statement. “The new facility will enable Colorcon to take advantage of new advances in process control and automation to manufacture a product that has over 40 years of history in use across the pharmaceutical industry.”
“Colorcon is committed to providing the highest quality products and superior service to meet our customers’ needs around the world,” said Jayesh Parmar, general manager, in the press statement. “This investment reinforces our dedication to providing continuity of supply and highlights our long-term commitment to the specialty excipient business.”
Source: Colorcon
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
